Business Description
Adicet Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US0070021086
Share Class Description:
ACET: Ordinary SharesDescription
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.36 | |||||
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 15.2 | |||||
3-Year EPS without NRI Growth Rate | 17.1 | |||||
3-Year FCF Growth Rate | 26.8 | |||||
3-Year Book Growth Rate | -11 | |||||
Future 3-5Y EPS without NRI Growth Rate | 20.23 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 84.27 | |||||
9-Day RSI | 73.05 | |||||
14-Day RSI | 64.14 | |||||
6-1 Month Momentum % | -47.04 | |||||
12-1 Month Momentum % | -46.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.34 | |||||
Quick Ratio | 14.34 | |||||
Cash Ratio | 14.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30 | |||||
Shareholder Yield % | -88.74 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -61.91 | |||||
ROA % | -53.1 | |||||
ROIC % | -207.18 | |||||
ROC (Joel Greenblatt) % | -302.81 | |||||
ROCE % | -57.16 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.5 | |||||
Price-to-Tangible-Book | 0.51 | |||||
EV-to-EBIT | 0.74 | |||||
EV-to-EBITDA | 0.78 | |||||
EV-to-Forward-EBITDA | -0.47 | |||||
EV-to-Forward-Revenue | 13.15 | |||||
EV-to-FCF | 1.09 | |||||
Price-to-Net-Current-Asset-Value | 0.61 | |||||
Price-to-Net-Cash | 0.62 | |||||
Earnings Yield (Greenblatt) % | 135.14 | |||||
FCF Yield % | -72.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ACET
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adicet Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.94 | ||
Beta | 1.6 | ||
Volatility % | 109.04 | ||
14-Day RSI | 64.14 | ||
14-Day ATR ($) | 0.098304 | ||
20-Day SMA ($) | 1.2445 | ||
12-1 Month Momentum % | -46.83 | ||
52-Week Range ($) | 1.05 - 3.77 | ||
Shares Outstanding (Mil) | 82.17 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Adicet Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Adicet Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Adicet Bio Inc Frequently Asked Questions
What is Adicet Bio Inc(ACET)'s stock price today?
The current price of ACET is $1.60. The 52 week high of ACET is $3.77 and 52 week low is $1.05.
When is next earnings date of Adicet Bio Inc(ACET)?
The next earnings date of Adicet Bio Inc(ACET) is 2024-08-09 Est..
Does Adicet Bio Inc(ACET) pay dividends? If so, how much?
Adicet Bio Inc(ACET) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |